ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
18.772,85
0,50%
S&P 500
5.222,68
0,16%
Dow Jones
39.512,84
0,32%
Euro vs US Dollar
1,07885
0,00%
Bitcoin
60.808,68
0,02%
Registration Strip Icon for discussion Registrieren Sie sich, um in unseren aktiven Foren mit gleichgesinnten Anlegern zu diskutieren.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NYSE
  6. Hercules Capital Inc (HTGC)

  7. Hercules Capital Inc (HTGC) News

HTGC

Hercules Capital (HTGC)

Hercules Capital Inc
Von:
Sortieren nach:
 Showing the most relevant articles for your search:NYSE:HTGC
DatumZeitQuelleÜberschriftSymbolFirma
09/05/202413h00GlobeNewswire Inc.Verona Pharma Announces $650 Million Strategic Financing with Oaktree and OMERSNYSE:HTGCHercules Capital Inc
07/05/202412h00Business WireHercules Capital Announces Upcoming Event for the Financial CommunityNYSE:HTGCHercules Capital Inc
02/05/202422h05Business WireHercules Capital Reports First Quarter 2024 Financial ResultsNYSE:HTGCHercules Capital Inc
30/04/202412h00Business WireHercules Capital Declares a Total Cash Distribution of $0.48 per Share for the First Quarter 2024NYSE:HTGCHercules Capital Inc
30/04/202409h00PR Newswire (US)SynOx Therapeutics secures up to $35m debt financing with Hercules Capital to progress development and commercialisation of emactuzumabNYSE:HTGCHercules Capital Inc
30/04/202409h00PR Newswire (US)SynOx Therapeutics secures up to $35m debt financing with Hercules Capital to progress development and commercialisation of emactuzumabNYSE:HTGCHercules Capital Inc
24/04/202412h00Business WireHercules Capital Celebrates 20th Anniversary with $20.0 Billion in Cumulative OriginationsNYSE:HTGCHercules Capital Inc
18/04/202412h00Business WireHercules Capital Announces Date for Release of First Quarter 2024 Financial Results and Conference CallNYSE:HTGCHercules Capital Inc
27/03/202411h00Business WireHercules Capital Receives BBB- Affirmed Investment Grade Credit and Corporate Rating from Fitch Ratings, Inc.NYSE:HTGCHercules Capital Inc
21/03/202411h00Business WireHercules Capital Receives Confirmed BBB Investment Grade Rating with Revised Outlook to Positive from Morningstar DBRSNYSE:HTGCHercules Capital Inc
20/02/202412h00Business WireHercules Capital Announces Upcoming Event for the Financial CommunityNYSE:HTGCHercules Capital Inc
15/02/202422h31Edgar (US Regulatory)Form 8-K - Current reportNYSE:HTGCHercules Capital Inc
15/02/202422h07Business WireHercules Capital Reports Fourth Quarter and Full-Year 2023 Financial ResultsNYSE:HTGCHercules Capital Inc
13/02/202412h02Business WireHercules Capital Declares a Total Cash Distribution of $0.48 per Share for the Fourth Quarter 2023NYSE:HTGCHercules Capital Inc
13/02/202412h00Business WireHercules Capital Announces New Supplemental Cash Distribution of $0.32 per ShareNYSE:HTGCHercules Capital Inc
30/01/202423h40Edgar (US Regulatory)Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]NYSE:HTGCHercules Capital Inc
30/01/202423h40Edgar (US Regulatory)Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]NYSE:HTGCHercules Capital Inc
30/01/202423h39Edgar (US Regulatory)Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]NYSE:HTGCHercules Capital Inc
25/01/202412h00Business WireHercules Capital Announces Date for Release of Fourth Quarter and Full-Year 2023 Financial Results and Conference CallNYSE:HTGCHercules Capital Inc
23/01/202422h05GlobeNewswire Inc.Sight Sciences Announces the Closing of up to $65 Million Senior Secured Credit Facility with Hercules CapitalNYSE:HTGCHercules Capital Inc
22/01/202417h23Edgar (US Regulatory)Form ABS-15G - Asset-backed securitizer report pursuant to Section 15GNYSE:HTGCHercules Capital Inc
18/01/202401h47Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:HTGCHercules Capital Inc
18/01/202401h47Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:HTGCHercules Capital Inc
18/01/202401h46Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:HTGCHercules Capital Inc
17/01/202402h29Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:HTGCHercules Capital Inc
17/01/202402h28Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:HTGCHercules Capital Inc
17/01/202402h28Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:HTGCHercules Capital Inc
17/01/202402h28Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:HTGCHercules Capital Inc
13/01/202400h30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:HTGCHercules Capital Inc
10/01/202422h44Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:HTGCHercules Capital Inc
 Showing the most relevant articles for your search:NYSE:HTGC

Kürzlich von Ihnen besucht

COIN
BTCUSD
Bitcoin
TG
432
Arbor Metals
TG
BAYN
Bayer
NYSE
JPM
JP Morgan Chase
TG
DBK
Deutsche Bank
DBI
SDXP
SDAX
NASDAQ
TSLA
Tesla
TG
DTE
Deutsche Telekom
NYSE
NKE
Nike
NASDAQ
MSFT
Microsoft
NASDAQ
AMZN
Amazon.com
NYSE
MRK
Merck
USOTC
RHHBY
Roche (QX)
TG
CBK
Commerzbank
CCOM
US500
US 500
AMEX
XLF
Financial Select Sector
Delayed Upgrade Clock
ADVFN Logo

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten